Conflict Of Ethics

AUTHOR: James W. Flesher, p.12 The Forrest Mims-Arthur Caplan debate discussed in The Scientist [Feb. 18, 1991, page 11; April 29, 1991, page 12; May 13, 1991, page 14] appears to be a classic case of conflict of religious and hedonist-libertarian ethics. The one was expressed by Mims [February 18 and May 13]; by letters from Mark Hartwig, Kevin Flynn, Walter Hearn, and James Stambaugh [April 29]; and, historically, by Newton and Einstein. The other was expressed by Caplan [February 18 and May

Written byJames Flesher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

AUTHOR: James W. Flesher, p.12

The Forrest Mims-Arthur Caplan debate discussed in The Scientist [Feb. 18, 1991, page 11; April 29, 1991, page 12; May 13, 1991, page 14] appears to be a classic case of conflict of religious and hedonist-libertarian ethics. The one was expressed by Mims [February 18 and May 13]; by letters from Mark Hartwig, Kevin Flynn, Walter Hearn, and James Stambaugh [April 29]; and, historically, by Newton and Einstein. The other was expressed by Caplan [February 18 and May 13]; by letters from Jerry Bergman, Daniel Atkinson, Thomas Jukes, and Tim Walker [April 29]; and by the editors of Scientific American. This latter group fears that Mims would promote creation theories in "The Amateur Scientist" column of Scientific American rather than evolution theories but presents no evidence to support this proposition. Their fears lead them to believe that his interpretation of scientific observations would not be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies